E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/10/2019 in the Prospect News Distressed Debt Daily.

Egalet reorganization plan accepted by majority of voting creditors

By Caroline Salls

Pittsburgh, Jan. 10 – Egalet Corp.’s amended plan of reorganization was accepted by a majority of voting creditors, according to a ballot report filed Thursday with the U.S. Bankruptcy Court for the District of Delaware.

The plan was accepted by all 18 voting holders of $66.27 million in first-lien secured notes claims.

In addition, 18 holders, or 85.71% in number, of $36.64 million, or 99.61% in amount, of convertible notes claims voted to accept the plan, while three holders, or 14.29% in number, of $143,781, or 0.39% in amount, of those claims voted to reject it.

The plan confirmation hearing is scheduled for Jan. 14.

Wayne, Pa.-based Egalet is a specialty pharmaceutical company focused on developing pain treatments. The company filed bankruptcy on Oct. 30 under Chapter 11 case number 18-12439.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.